http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S59116229-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-866
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6881
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-544
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
filingDate 1982-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1c98b659ca083b35430f2c170e21180
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aaa5a7635cb4120b8648490ef868c472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e71e6b4ccec00a1d6f1a2568df45251e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9120cd07079929f86b397bba91c4e950
publicationDate 1984-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S59116229-A
titleOfInvention Cell toxicity complex and its preparation
abstract PURPOSE: The complex obtained by linking a specific immunoglobulin or its fragment to serum albumin combined with a cell toxicity substance by a covalent bond. n CONSTITUTION: An immunoglobulin (e.g., IgG, IgA, IgM, IgD, or IgE) capable of combining specifically with a specific antigen which a cell to be killed has hand, or its fragment is linked to serum albumin combined with a cell toxicity substance (e.g., complex shown by the formula I , etc.) by a covalent bond, to give a cell toxicity complex {e.g., a complex shown by the formula II (Ab is immunoglobulin or its fragment; Al is serum albumin; Cy is cell toxicity substance; S 1 and NH are S and imino in the serum albumin; B 1 is bifunctional organic group; m is 1W30; n is 1W10), etc.}. In the linking by a covalent bond, both of them are blended with a crosslinking agent, the three may be simultaneously brought into contact with one another, however, preferably one of the proteins is reacted with the crosslinking agent, and the reaction product is reacted with the other. n COPYRIGHT: (C)1984,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S60172935-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001500133-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006056907-A
priorityDate 1982-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJD2
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24186
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009195
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJC5
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397158
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11657
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID213
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3T478
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280717
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100034206

Total number of triples: 40.